Get started
Author

Michael Bayne

Observed names: M. Bayne, M.C. Bayne, Michael C. Bayne
OpenAlex ID: A5081439513
Reproducibility of “Intelligent” Contouring of Gross Tumor Volume in Non–Small-Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method
2010 · Michael Bayne, Rodney J. Hicks, et al. · International Journal of Radiation Oncology*Biology*Physics · 68
Recommendations for the Use of Radiotherapy in Nodal Lymphoma
2012 · P.J. Hoskin, P. Díez, et al. · Clinical Oncology · 63
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
2016 · David B. Landau, Laura Hughes, et al. · International Journal of Radiation Oncology*Biology*Physics · 43
PDF
LYMRIT 37-01: A Phase I/II Study of 177lu-Lilotomab Satetraxetan (Betalutin®) Antibody-Radionuclide-Conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin's Lymphoma (NHL) — Analysis with 6-Month Follow-up
2018 · Arne Kolstad, Ulf Madsbu, et al. · Blood · 11
In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4–5
2004 · Michael MacManus, Rod Hicks, et al. · International Journal of Radiation Oncology*Biology*Physics · 10
Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al. (Int J Radiat Oncol Biol Phys 2004;60:1272–1282)
2005 · Michael Bayne, Michael MacManus, et al. · International Journal of Radiation Oncology*Biology*Physics · 9
Recommendations for Radiotherapy Technique and Dose in Extra-nodal Lymphoma
2015 · P.J. Hoskin, P. Díez, et al. · Clinical Oncology · 8
Fractionated 90y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria
2011 · Timothy M Illidge, Ruth Pettengell, et al. · Blood · 7
Lymrit 37‐01: Updated Results of a Phase I/ii Study of 177lu‐lilotomab Satetraxetan, a Novel Cd37‐targeted Antibody‐ Radionuclide‐conjugate in Relapsed Nhl Patients
2017 · A. Kolstad, U. Madsbu, et al. · Hematological Oncology · 5
PDF
5CT based brachytherapy planning and complimentary bioeffect dosimetry: Evaluation of combined brachytherapy and external beam radiotherapy dose distributions, in the treatment of cervical cancer
2001 · J. Nevinson, T.M. lllidge, et al. · Radiotherapy and Oncology · 5
Abstract LB-252: Efficacy and safety results of Betalutin® (177Lu-DOTA-HH1) in a phase I/II study of patients with non-hodgkin B-cell lymphoma (NHL)
2016 · Arne Kolstad, Ulf Madsbu, et al. · Cancer Research · 3
177lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimens
2016 · Arne Kolstad, Ulf Madsbu, et al. · Blood · 2
2457
2006 · M. MacManus, M. Bayne, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
PDF
Ninety Day Mortality and Overall Survival after Radical Radiotherapy for Non-small Cell Lung Cancer
2017 · S.K. Prince, M. Roberts, et al. · Clinical Oncology
The Health Related Quality of Life Is Maintained Following Treatment of Indolent Non-Hodgkin's Lymphoma Patients with the Novel Effective Antibody Radionuclide Conjugate 177lu-Satetraxetan-Lilotomab
2016 · Arne Kolstad, Matthew Beasley, et al. · Blood
Results of a Prospective Clinical Trial of FDG-PET/CT Scanning for Staging and Treatment Planning in Candidates for Radical Radiation Therapy with Unresectable Non-small Cell Lung Cancer
2010 · M.P. MacManus, A. Herschtal, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
A20 Phase I/II study of fractionated radioimmunotherapy in relapsed low grade non-Hodgkin??s lymphoma
2006 · M.A. Zivanovic, M.C. Bayne, et al. · Nuclear Medicine Communications
P-703 Fused PET/CT images for planning radical radiotherapy (RRT) fornon-small cell lung cancer (NSCLC)
2005 · M. Bayne, S. Everitt, et al. · Lung Cancer
Works count: 18
Citation count: 236
H-index: 7
I10-index: 5
Year
Topic
Type